Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma

This publication has 35 references indexed in Scilit:

• A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
  Journal of Hematology & Oncology, 2013
• Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
  Investigational New Drugs, 2012
• SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
  Blood, 2012
• Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
  Leukemia & Lymphoma, 2011
• Extranodal NK/T-cell lymphoma nasal type: Efficacy of pegaspargase. Report of two patients from the United Sates and review of literature
  Leukemia Research, 2010
• Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
  Blood, 2009
• Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
  Annals of Oncology, 2009
• Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
  The Korean Journal of Internal Medicine, 2009
• Revised Response Criteria for Malignant Lymphoma
  Journal of Clinical Oncology, 2007
• CD56⁺ NK lymphomas:clinicopathological features and prognosis
  British Journal of Haematology, 1997